Found 24 matching trials
Efficacy and Safety of Alirocumab in Patients With Hypercholesterolemia Not Adequately Controlled With Non-statin Lipid Modifying Therapy or the Lowest Strength of Statin PHASE3 Primary Objective:
To demonstrate the reduction of low-density lipoprotein...
Show More Location
Investigational Site Number 392028
Learn More & Join Trial
Treatment of HDL to Reduce the Incidence of Vascular Events HPS2-THRIVE PHASE3 The primary aim is to assess the effects of raising HDL cholesterol (the go...
Show More Location
Clinical Trial Service Unit, University of Oxford
Learn More & Join Trial
Active Choice in the EHR to Promote Statin Therapy NA Cardiovascular (CV) events are the leading cause of mortality in the United...
Show More Location
University of Pennsylvania
Learn More & Join Trial
Efficacy and Safety of Pitavastatin and PCSK9 Inhibitors in Liver Transplant Patients PHASE4 To study the efficacy and safety of pitavastatin and PCSK9 inhibitors in li...
Show More Status
Active Not Recruiting
Location
National Medical Research Centre for Therapy and Preventive Medicine of the Ministry of Health of Russia
Learn More & Join Trial
Efficacy and Safety of Gemcabene in Hypercholesterolemic Patients on Stable Statin Therapy PHASE2 The purpose of this study is to evaluate the effect of gemcabene on LDL-C a...
Show More Location
Multiple Locations
Learn More & Join Trial
Evaluation of the Efficacy and Safety of Bempedoic Acid (ETC-1002) in Patients With Hyperlipidemia and Statin Intolerant PHASE3 The purpose of this study is to determine if bempedoic acid (ETC-1002) is e...
Show More Location
Multiple Locations
Learn More & Join Trial
Alirocumab for Stabilisation of Symptomatic Vulnerable Carotid Plaque PHASE3 CAROTID-STABILISE is a phase III, multicentre, randomised, double-blind, pl...
Show More Location
Alexandria University, Smouha University Comprehensive Stroke Center
Learn More & Join Trial
A Study to Investigate LDL-cholesterol Lowering With Inclisiran Compared to Bempedoic Acid in Patients With Atherosclerotic Cardiovascular Disease. PHASE4 This study is a phase IV, open-label, randomized study designed to evaluate...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
GALLANT 14 Tesaglitazar vs. Metformin and Fenofibrate PHASE3 This is a 24-week study to determine the lipid metabolic effects, safety, a...
Show More Learn More & Join Trial
Phase 2a Study to Assess CIVI 007 in Patients on a Background of Statin Therapy PHASE2 Evaluation of the clinical profile (lipid efficacy, safety and PK) across a...
Show More Learn More & Join Trial